PDLIM5 Antibody (OTI1B5) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-73316JF669
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse, Rat
Applications
Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # OTI1B5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PDLIM5 Antibody (OTI1B5) [Janelia Fluor® 669]
Immunogen
Full length human recombinant protein of human PDLIM5(NP_006448) produced in HEK293T cell.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for PDLIM5 Antibody (OTI1B5) [Janelia Fluor® 669]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PDLIM5
Alternate Names
Enh, ENH1, ENHLIM, Enigma homolog, enigma-like LIM domain protein, Enigma-like PDZ and LIM domains protein, PDZ and LIM domain 5, PDZ and LIM domain protein 5
Gene Symbol
PDLIM5
Additional PDLIM5 Products
Product Documents for PDLIM5 Antibody (OTI1B5) [Janelia Fluor® 669]
Product Specific Notices for PDLIM5 Antibody (OTI1B5) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...